85 related articles for article (PubMed ID: 10780313)
21. A case of pseudothrombocytopenia after infusion of abciximab in vivo and anticoagulant-independent platelet clumping after rechallenge with abciximab in vitro.
Kozak M; Dovc T; Rozman P; Blinc A
Wien Klin Wochenschr; 2000 Feb; 112(3):138-41. PubMed ID: 10729966
[TBL] [Abstract][Full Text] [Related]
22. Initial experience with an intravenous P2Y12 platelet receptor antagonist in patients undergoing percutaneous coronary intervention: results from a 2-part, phase II, multicenter, randomized, placebo- and active-controlled trial.
Greenbaum AB; Grines CL; Bittl JA; Becker RC; Kereiakes DJ; Gilchrist IC; Clegg J; Stankowski JE; Grogan DR; Harrington RA; Emanuelsson H; Weaver WD
Am Heart J; 2006 Mar; 151(3):689.e1-689.e10. PubMed ID: 16504633
[TBL] [Abstract][Full Text] [Related]
23. Monitoring aspirin treatment in patients with thrombocytosis: comparison of the platelet function analyzer (PFA)-100 with optical aggregometry.
Tsantes AE; Mantzios G; Giannopoulou V; Tsirigotis P; Bonovas S; Rapti E; Mygiaki E; Kartasis Z; Sitaras NM; Dervenoulas J; Travlou A
Thromb Res; 2008; 123(1):100-7. PubMed ID: 18430462
[TBL] [Abstract][Full Text] [Related]
24. Free and total platelet glycoprotein IIb/IIIa measurement in whole blood by quantitative flow cytometry during and after infusion of c7E3 Fab in patients undergoing PTCA.
Hézard N; Metz D; Nazeyrollas P; Nguyen P; Simon G; Daliphard S; Droullé C; Elaerts J; Potron G
Thromb Haemost; 1999 Jun; 81(6):869-73. PubMed ID: 10404759
[TBL] [Abstract][Full Text] [Related]
25. Increased morning ADP-dependent platelet aggregation persists despite dual antiplatelet therapy in patients with first ST-segment elevation myocardial infarction: Preliminary report.
Koziński M; Bielis L; Wiśniewska-Szmyt J; Sukiennik A; Grabczewska Z; Swiatkiewicz I; Ziołkowski M; Rość D; Kubica J
Cardiol J; 2008; 15(6):530-6. PubMed ID: 19039757
[TBL] [Abstract][Full Text] [Related]
26. Flow cytometric observations on the in vivo use of Fab fragments of a chimaeric monoclonal antibody to platelet glycoprotein IIb-IIIa.
Christopoulos C; Mackie I; Lahiri A; Machin S
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):729-37. PubMed ID: 8292722
[TBL] [Abstract][Full Text] [Related]
27. The risk of false results in the assessment of platelet function in the absence of antiplatelet medication: comparison of the PFA-100, multiplate electrical impedance aggregometry and verify now assays.
Can MM; Tanboğa IH; Türkyilmaz E; Karabay CY; Akgun T; Koca F; Tokgoz HC; Keles N; Ozkan A; Bezgin T; Ozveren O; Sonmez K; Sağlam M; Ozdemir N; Kaymaz C
Thromb Res; 2010 Apr; 125(4):e132-7. PubMed ID: 19954823
[TBL] [Abstract][Full Text] [Related]
28. Safety and efficacy of low-dose unfractionated heparin during percutaneous coronary revascularisation and the relationship between activated clotting time and haemorrhagic or ischaemic complications: our results.
Capuano C; Sesana M; Leonzi O; Cuccia C
J Cardiovasc Med (Hagerstown); 2006 Dec; 7(12):866-71. PubMed ID: 17122672
[TBL] [Abstract][Full Text] [Related]
29. Safety, inhibition of platelet aggregation and pharmacokinetics of Fab'2 fragments of the anti-glycoprotein IIb-IIIa monoclonal antibody FRaMon in high-risk coronary angioplasty.
Mazurov AV; Pevzner DV; Antonova OA; Byzova TV; Khaspekova SG; Semenov AV; Vlasik TN; Samko AN; Staroverov II; Ruda MY
Platelets; 2002 Dec; 13(8):465-77. PubMed ID: 12487780
[TBL] [Abstract][Full Text] [Related]
30. Dosing and administration of ReoPro (c7E3 Fab).
Tcheng JE
J Invasive Cardiol; 1994; 6 Suppl A():29A-33A; discussion 51A-54A. PubMed ID: 10155091
[No Abstract] [Full Text] [Related]
31. Pharmacodynamics of abciximab during angioplasty: comparison to healthy subjects.
Abernethy DR; Pezzullo J; Mascelli MA; Frederick B; Kleiman NS; Freedman J
Clin Pharmacol Ther; 2002 Mar; 71(3):186-95. PubMed ID: 11907493
[TBL] [Abstract][Full Text] [Related]
32. Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100.
Homoncik M; Jilma B; Hergovich N; Stohlawetz P; Panzer S; Speiser W
Thromb Haemost; 2000 Feb; 83(2):316-21. PubMed ID: 10739392
[TBL] [Abstract][Full Text] [Related]
33. Effects of aspirin and clopidogrel in healthy men measured by platelet aggregation and PFA-100.
Madsen EH; Schmidt EB; Maurer-Spurej E; Kristensen SR
Platelets; 2008 Aug; 19(5):335-41. PubMed ID: 18791939
[TBL] [Abstract][Full Text] [Related]
34. Platelet function predicts myocardial damage in patients with acute myocardial infarction.
Frossard M; Fuchs I; Leitner JM; Hsieh K; Vlcek M; Losert H; Domanovits H; Schreiber W; Laggner AN; Jilma B
Circulation; 2004 Sep; 110(11):1392-7. PubMed ID: 15313953
[TBL] [Abstract][Full Text] [Related]
35. Value of platelet reactivity in predicting response to treatment and clinical outcome in patients undergoing primary coronary intervention: insights into the STRATEGY Study.
Campo G; Valgimigli M; Gemmati D; Percoco G; Tognazzo S; Cicchitelli G; Catozzi L; Malagutti P; Anselmi M; Vassanelli C; Scapoli G; Ferrari R
J Am Coll Cardiol; 2006 Dec; 48(11):2178-85. PubMed ID: 17161242
[TBL] [Abstract][Full Text] [Related]
36. A modified thromboelastographic method for monitoring c7E3 Fab in heparinized patients.
Greilich PE; Alving BM; O'Neill KL; Chang AS; Reid TJ
Anesth Analg; 1997 Jan; 84(1):31-8. PubMed ID: 8988995
[TBL] [Abstract][Full Text] [Related]
37. Leukocyte-platelet aggregation, platelet surface P-selectin, and platelet surface glycoprotein IIIa after percutaneous coronary intervention: Effects of dalteparin or unfractionated heparin in combination with abciximab.
Furman MI; Kereiakes DJ; Krueger LA; Mueller MN; Pieper K; Broderick TM; Schneider JF; Howard WL; Fox ML; Barnard MR; Frelinger AL; Michelson AD
Am Heart J; 2001 Nov; 142(5):790-8. PubMed ID: 11685164
[TBL] [Abstract][Full Text] [Related]
38. A microchip flow-chamber system for quantitative assessment of the platelet thrombus formation process.
Hosokawa K; Ohnishi T; Fukasawa M; Kondo T; Sameshima H; Koide T; Tanaka KA; Maruyama I
Microvasc Res; 2012 Mar; 83(2):154-61. PubMed ID: 22166857
[TBL] [Abstract][Full Text] [Related]
39. In vitro bleeding test with PFA-100-aspects of controlling individual acetylsalicylic acid induced platelet inhibition in patients with cardiovascular disease.
Peters AJ; Borries M; Gradaus F; Jax TW; Schoebel FC; Strauer BE
J Thromb Thrombolysis; 2001 Dec; 12(3):263-72. PubMed ID: 11981109
[TBL] [Abstract][Full Text] [Related]
40. Images in cardiovascular medicine. Abciximab-associated pseudothrombocytopenia.
Holmes MB; Kabbani S; Watkins MW; Battle RW; Schneider DJ
Circulation; 2000 Feb; 101(8):938-9. PubMed ID: 10694535
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
